PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Royal DSM N.V.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

DSM Enzymes for Cellulosic Ethanol Qualified by DONG Energy - Royal DSM, the global Life Sciences and Materials Sciences company, has been qualified as supplier of enzymes for DONG Energy - Inbicon’s wheat straw to cellulosic ethanol process - DONGenergy.com / DSM.com
DSM Enzymes for Cellulosic Ethanol Qualified by DONG Energy

 

NewswireToday - /newswire/ - Heerlen, NL, Netherlands, 2012/06/05 - Royal DSM, the global Life Sciences and Materials Sciences company, has been qualified as supplier of enzymes for DONG Energy - Inbicon’s wheat straw to cellulosic ethanol process - DONGenergy.com / DSM.com. Euronext: DSM KON

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The enzymes have been successfully used in the demonstration scale biorefinery of DONG Energy - Inbicon in Kalundborg, Denmark. The qualification reconfirms the high standard and flexibility of DSM’s cocktail of enzymes to break down and convert the cellulose and hemicellulose from the straw fibers into simple C5 and C6 sugars. DONG Energy - Inbicon Biomass Refinery is the world’s largest scale cellulosic ethanol demonstration plant that is currently in operation. The plant has a capacity of 1.5 million gallons a year and produces cellulosic biofuel for Statoil which is distributed via gasoline stations throughout Denmark.

DSM’s enzyme cocktail is particularly effective at breaking down cellulosic biomass to component sugars while having a very high thermal stability. Because of this the hydrolysis step can be performed at higher temperatures, while decreasing the risk of product loss. Higher operating temperatures also increase process speed and ultimately lead to a reduction of the amount of enzyme needed.

DSM’s enzymes have been proven in multiple tests at various scales by research institutes and company labs across the globe to be working across multiple feedstocks, including corn crop residue, wheat straw, wood chips and sugarcane bagasse. They have also been tested on the full range of pre-treatment, from very harsh to relatively mild (as is the case in the Inbicon process), giving supportive evidence to the versatility of the DSM enzyme system. The break down or pre-treatment of crop residue is the first phase of the conversion process towards cellulosic bio-ethanol.

DSM (dsm.com) selected its enzymes using the biomass as the starting point for the selection process. These are substrates that are expected to be commercially leading in future production of cellulosic bio-ethanol.

Jan Larsen, head of R&D Inbicon, says: “The DSM enzyme cocktail has performed successfully in the Inbicon process at demonstration scale. It showed the same high yield as was obtained in pilot scale. This cocktail has both a broad pH range and high temperature tolerance which make DSM’s enzymes very favorable for industrial production of cellulosic bio-ethanol at high dry matters. The technical reports and analysis from the test program are now finalized and we conclude that the DSM enzymes are now qualified for the Inbicon process."

Stephan Tanda, member of the DSM Managing Board, comments: “We are proud to receive Inbicon’s endorsement of our enzymes technology. This additional qualification strengthens DSM’s global enzyme position and confirms our drive to being a technology partner for cellulosic bio-ethanol producing companies across the globe. DSM offers the broadest technology currently available in the market, with high performing enzymes and yeasts that are able to convert a large variety of biomass into cellulosic ethanol.”

About DONG Energy - Inbicon A/S

DONG Energy (dongenergy.com) - Inbicon A/S develops technology for conversion and refining of soft ligno-cellulosic biomass into fuel, feed, and green chemistry products. The company has operated a pilot plant since 2003, and in December 2009 the first Inbicon Biomass Refinery was inaugurated in Kalundborg, Denmark, to demonstrate the technology. The plant converts wheat straw into fuel grade ethanol, animal feed, and lignin pellets for energy production. Inbicon (inbicon.com) is a subsidiary of DONG Energy A/S and organized under the business unit New Bio Solutions.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Royal DSM N.V.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


DSM Enzymes for Cellulosic Ethanol Qualified by DONG Energy

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Royal DSM N.V. | DONG Energy
Publisher Contact: Herman Betten - DSM.com 
+31(0) 45 5782017 media.relations[.]dsm.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Royal DSM N.V. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Royal DSM N.V. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)